News

Slideshow

Major Depressive Disorder Pharmaceutical Research Updates

Author(s):

Megan McSweeney

Check out these updates on research including major depressive disorder (MDD).

Related Videos
electric brain
DBS
schizophrenia
clozapine
brain
40 years
Have A Nice Day Photo/AdobeStock
Tasphong/AdobeStock
Andrey/AdobeStock
Related Content
pills
April 30th 2025

April in Review: Updates on the Psychiatric Treatment Pipeline

Leah Kuntz
Here's to a Psychedelic Revolution
April 9th 2022

Here's to a Psychedelic Revolution

Amir Inamdar MBBS, DNB (Psych), MFPM
clinical study
April 24th 2025

Preliminary Results from RESTORE-LIFE Shows Promise for VNS in Difficult to Treat Depression

Grace Koennecke
Blue Light Blockers: A Behavior Therapy for Mania
October 7th 2021

Blue Light Blockers: A Behavior Therapy for Mania

Chris Aiken, MD Kellie Newsome, PMH-NP
business partners
April 22nd 2025

Cybin Announces Partnership With Osmind to Advance Clinical-Stage Psychiatry Programs

Leah Kuntz
clinical trial
April 21st 2025

MindMed Begins Phase 3 Emerge Study of MM120 in Patients With Major Depressive Disorder

Grace Koennecke
© 2025 MJH Life Sciences

All rights reserved.